Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Separate ministry for...

    Separate ministry for pharma in next one year: Ananth Kumar

    Written by savita thakur thakur Published On 2015-12-10T13:51:56+05:30  |  Updated On 10 Dec 2015 1:51 PM IST
    Separate ministry for pharma in next one year: Ananth Kumar
    New Delhi: Union Fertilisers Minister Ananth Kumar said there will be a separate ministry for pharma and medical devices sector in the next one year, and assured that the government will soon implement the Katoch panel recommendations to cut bulk drugs import from China.

    "I want to see that pharmaceutical and medical devices become a separate ministry and we are already in touch with PMO and we are pursuing that it becomes a separate ministry. I assure you in next one year you will emerge as a separate entity as pharma and medical devices ministry," Kumar said at an event organised by PHD Chamber of Commerce.

    He added that the government recognises the pharma sector as a 'sunshine industry' having a tremendous potential for growth.

    Kumar said that in order to benefit the domestic pharma industry, the government plans to implement the recommendations by the Katoch Committee in the next 100 days.

    "In the next 100 days, we are going to implement the Katoch committee report for the benefit of the pharma industry. We have already accepted it, it is in circulation. We are having discussions with the PMO also, and to implement some of the recommendations even if we have to go to the Cabinet, we will go," the Minister said.

    The government had set set up a committee headed by V M Katoch, Secretary, Health Research, to suggest ways to reduce the dependence on bulk drug imports from China.

    India currently meets about 80 per cent of its demand of bulk drugs or API, used as raw materials by the pharmaceutical industry, from Chinese imports.

    On the inverted duty structure hampering the pharma and medical devices industries, Kumar said the government has been following up the issue for the last one-and-a-half years.

    "There is a huge question of FTA and inverted duty structure which needs to be attempted...I request office bearers of PHD Chamber of Commerce to come out with a memorandum regarding these inverted duties which will be discussed with the finance ministry itself before the Budget, that is an assurance," Kumar said.

    "I will lead the delegation...and we will put forth the concerns of the industry regarding this inverted duty structure," he added.

    Kumar also ruled out doing away with the price control on essential and life savings drugs asserting that the Modi government is pro-poor though assured that Industry will continue to be consulted.

    On price control mechanism, Kumar said: "...I have not seen any sector in India without any regulation...Industry should not be saying that we would set our own benchmarks, we will set our own quality control, we will testify ourselves and it is the best, we don't require any regulation...we have 10,000 registered drug entrepreneurs in this country and what type of medicines they are producing, you also know and I also know."

    "Unfortunately in our country there are populations of different economic strata. We have population in remote places, you (industries) don't go there. Therefore, all these things are there, the state has to intervene regarding quality, availability, affordability, we can't run away from our duty," he added.

    He further said the government, for the betterment of people, is in the process of revising the National List of Essential Medicines (NLEM) 2011.

    "It is Health Ministry's mandate to make NLEM list, they are improving the list and we have also given our points to them as to what should be added in the list. Blood pressure, cardiac, cancer, HIV/AIDS medicines should be added," Kumar said.

    He also directed the Secretary Department of Pharmaceuticals V K Subburaj to initiate discussions regarding various IPR issue.

    When asked about the recommendations of the committee constituted to look into pharma product margins, Kumar said: "We had constituted a committee that committee has submitted its report to us. We are going to come out with a decision regarding this report very soon.Union Fertilisers Minister Ananth Kumar
    [poll id=35762]
    NLEMpharma ministrypharma newsUnion Fertilisers Minister Ananth Kumar
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok